Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, el Gamal MI (1995) Fractional flow reserve. a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92:3183–3193

Article  CAS  PubMed  Google Scholar 

Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van’t Veer M, Pijls NH (2010) Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 55:2816–2821

Article  PubMed  Google Scholar 

De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF, FAME 2 Trial Investigators (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001

Article  PubMed  Google Scholar 

Tanaka N, Nakamura M, Akasaka T, Kadota K, Uemura S, Amano T, Shiode N, Morino Y, Fujii K, Hikichi Y, CVIT-DEFER Registry Investigators (2017) One-year outcome of fractional flow reserve-based coronary intervention in Japanese daily practice-CVIT-DEFER registry. Circ J 81:1301–1306

Article  PubMed  Google Scholar 

Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, Fearon WF, Barbato E, Kern MJ, Pijls NH, De Bruyne B (2016) Standardization of fractional flow reserve measurements. J Am Coll Cardiol 68:742–753

Article  PubMed  Google Scholar 

Johnson NP, Johnson DT, Kirkeeide RL, Berry C, De Bruyne B, Fearon WF, Oldroyd KG, Pijls NHJ, Gould KL (2015) Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. JACC Cardiovasc Interv 8:1018–1027

Article  PubMed  Google Scholar 

Matsumoto H, Nakatsuma K, Shimada T, Ushimaru S, Mikuri M, Yamazaki T, Matsuda T (2014) Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement. J Invasive Cardiol 26:580–585

PubMed  Google Scholar 

Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD (1990) Effects of adenosine on human coronary arterial circulation. Circulation 82:1595–1606

Article  CAS  PubMed  Google Scholar 

Seto AH, Tehrani DM, Bharmal MI, Kern MJ (2014) Variations of coronary hemodynamic responses to intravenous adenosine infusion: implications for fractional flow reserve measurements. Catheter Cardiovasc Interv 84:416–425

Article  PubMed  Google Scholar 

Zhang Y, Wernly B, Cao X, Mustafa SJ, Tang Y, Zhou Z (2021) Adenosine and adenosine receptor-mediated action in coronary microcirculation. Basic Res Cardiol 116:22

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho MF, Low LM, Rose’Meyer RB (2016) Pharmacology of the adenosine A3 receptor in the vasculature and essential hypertension. PLoS ONE 11:e0150021

Article  PubMed  PubMed Central  Google Scholar 

Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH (2009) Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234:683–692

Article  CAS  PubMed  Google Scholar 

Zhou Z, de Wijs-Meijler D, Lankhuizen I, Jankowski J, Jankowski V, Jan Danser AH, Duncker DJ, Merkus D (2013) Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation. Pharmacol Res 77:22–29

Article  CAS  PubMed  Google Scholar 

De Bruyne B, Pijls NH, Bartunek J, Kulecki K, Bech JW, De Winter H, Van Crombrugge P, Heyndrickx GR, Wijns W (2001) Fractional flow reserve in patients with prior myocardial infarction. Circulation 104:157–162

Article  PubMed  Google Scholar 

Kofflard MJ, Michels M, Krams R, Kliffen M, Geleijnse ML, Ten Cate FJ, Serruys PW (2007) Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics. Neth Heart J 15:209–215

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang HJ, Koo BK, Lee HS, Park JB, Kim JH, Seo MK, Yang HM, Park KW, Nam CW, Doh JH, Kim HS (2013) Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J 34:2055–2062

Article  CAS  PubMed  Google Scholar 

Tanaka N, Takahashi Y, Ishihara H, Kawakami T, Ono H (2015) Usefulness and safety of intracoronary administration of nicorandil for evaluating fractional flow reserve in Japanese patients. Clin Cardiol 38:20–24

Article  PubMed  PubMed Central  Google Scholar 

Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, Kuhara Y, Ando H, Maeda K, Kumagai S, Sakurai S, Suzuki A, Toda Y, Watanabe A, Sato S, Fujimoto M, Mizuno T, Amano T (2015) Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessel 30:477–483

Article  Google Scholar 

Markham A, Plosker GL, Goa KL (2000) Nicorandil. an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs 60:955–974

Article  CAS  PubMed  Google Scholar 

Ishibuchi K, Fujii K, Otsuji S, Takiuchi S, Hasegawa K, Tamaru H, Ishii R, Yasuda S, Nakabayashi S, Yamamoto W, Kusumoto H, Taniguchi Y, Kakishita M, Shimatani Y, Higashino Y (2019) Utility and validity of intracoronary administration of nicorandil alone for the measurement of fractional flow reserve in patients with intermediate coronary stenosis. Circ J 83:2010–2016

Article  CAS  PubMed  Google Scholar 

Takami H, Sonoda S, Muraoka Y, Sanuki Y, Kashiyama K, Fukuda S, Oginosawa Y, Tsuda Y, Araki M, Otsuji Y (2017) Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5’-triphosphate infusion. J Cardiol 69:119–124

Article  PubMed  Google Scholar 

Matsumoto H, Mikuri M, Masaki R, Tanaka H, Ogura K, Arai T, Sakai R, Oishi Y, Okada N, Shinke T (2020) Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: comparison with intracoronary papaverine. Int J Cardiol 314:1–6

Article  PubMed  Google Scholar